CVS Health (CVS) PT Lowered to $58 at RBC Capital

November 15, 2024 6:31 AM EST Send to a Friend
RBC Capital analyst Anton Hie lowered the price target on CVS Health (NYSE: CVS) to $58.00 (from $68.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login